MXPA01008185A - Cosmetic compositions containing vitamin b3 - Google Patents
Cosmetic compositions containing vitamin b3Info
- Publication number
- MXPA01008185A MXPA01008185A MXPA/A/2001/008185A MXPA01008185A MXPA01008185A MX PA01008185 A MXPA01008185 A MX PA01008185A MX PA01008185 A MXPA01008185 A MX PA01008185A MX PA01008185 A MXPA01008185 A MX PA01008185A
- Authority
- MX
- Mexico
- Prior art keywords
- vitamin
- compound
- further characterized
- lipstick
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 189
- 239000002537 cosmetic Substances 0.000 title claims abstract description 44
- 235000013343 vitamin Nutrition 0.000 title description 4
- 239000011782 vitamin Substances 0.000 title description 4
- 229930003231 vitamins Natural products 0.000 title description 4
- 229940088594 Vitamin Drugs 0.000 title description 3
- 150000003722 vitamin derivatives Chemical class 0.000 title description 3
- 229960003512 nicotinic acid Drugs 0.000 claims abstract description 87
- 229930003537 Vitamin B3 Natural products 0.000 claims abstract description 66
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims abstract description 66
- 235000019160 vitamin B3 Nutrition 0.000 claims abstract description 66
- 239000011708 vitamin B3 Substances 0.000 claims abstract description 66
- 210000003491 Skin Anatomy 0.000 claims abstract description 56
- 239000003974 emollient agent Substances 0.000 claims abstract description 44
- 239000002245 particle Substances 0.000 claims abstract description 36
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 23
- -1 vitamin B3 compound Chemical class 0.000 claims description 106
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 64
- 229940053487 Niacinamide Drugs 0.000 claims description 55
- 235000005152 nicotinamide Nutrition 0.000 claims description 55
- 239000011570 nicotinamide Substances 0.000 claims description 55
- 229960003966 nicotinamide Drugs 0.000 claims description 55
- 239000003921 oil Substances 0.000 claims description 32
- 235000001968 nicotinic acid Nutrition 0.000 claims description 22
- 239000011664 nicotinic acid Substances 0.000 claims description 22
- 150000003839 salts Chemical class 0.000 claims description 19
- 239000011780 sodium chloride Substances 0.000 claims description 19
- 150000002148 esters Chemical class 0.000 claims description 11
- 239000002798 polar solvent Substances 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 claims description 5
- 229950009883 tocopheryl nicotinate Drugs 0.000 claims description 5
- 230000035807 sensation Effects 0.000 claims description 3
- 230000000699 topical Effects 0.000 claims description 3
- 230000000304 vasodilatating Effects 0.000 claims description 2
- 238000009826 distribution Methods 0.000 abstract description 5
- 239000000463 material Substances 0.000 description 36
- 239000004615 ingredient Substances 0.000 description 30
- 239000001993 wax Substances 0.000 description 28
- 235000019198 oils Nutrition 0.000 description 27
- 239000002904 solvent Substances 0.000 description 27
- 210000000088 Lip Anatomy 0.000 description 19
- 235000019388 lanolin Nutrition 0.000 description 18
- 235000019441 ethanol Nutrition 0.000 description 17
- 239000007788 liquid Substances 0.000 description 17
- 239000000049 pigment Substances 0.000 description 17
- 239000004166 Lanolin Substances 0.000 description 16
- 229940039717 Lanolin Drugs 0.000 description 16
- 239000004922 lacquer Substances 0.000 description 16
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 14
- 229920001888 polyacrylic acid Polymers 0.000 description 14
- 239000004359 castor oil Substances 0.000 description 13
- 235000019438 castor oil Nutrition 0.000 description 13
- 239000002781 deodorant agent Substances 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 239000002585 base Substances 0.000 description 12
- 235000014113 dietary fatty acids Nutrition 0.000 description 12
- 239000000194 fatty acid Substances 0.000 description 12
- 229910052782 aluminium Inorganic materials 0.000 description 11
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 11
- 239000000499 gel Substances 0.000 description 11
- 150000001298 alcohols Chemical class 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 10
- 235000019634 flavors Nutrition 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 239000003981 vehicle Substances 0.000 description 10
- 150000004665 fatty acids Chemical class 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- 239000012071 phase Substances 0.000 description 9
- QELSKZZBTMNZEB-UHFFFAOYSA-N Propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 8
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 8
- 229960003415 propylparaben Drugs 0.000 description 8
- 239000004094 surface-active agent Substances 0.000 description 8
- 239000003086 colorant Substances 0.000 description 7
- 238000002425 crystallisation Methods 0.000 description 7
- 230000005712 crystallization Effects 0.000 description 7
- 239000000975 dye Substances 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 230000004927 fusion Effects 0.000 description 7
- 239000003349 gelling agent Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 229920005989 resin Polymers 0.000 description 7
- 239000011347 resin Substances 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 238000007711 solidification Methods 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- 150000003626 triacylglycerols Chemical class 0.000 description 7
- FJCFFCXMEXZEIM-UHFFFAOYSA-N 1-oxidopyridin-1-ium-3-carboxylic acid Chemical compound OC(=O)C1=CC=C[N+]([O-])=C1 FJCFFCXMEXZEIM-UHFFFAOYSA-N 0.000 description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N Cetyl alcohol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- 229940093629 ISOPROPYL ISOSTEARATE Drugs 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 239000003995 emulsifying agent Substances 0.000 description 6
- 150000002191 fatty alcohols Chemical class 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 229960005150 glycerol Drugs 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- PVRKSMXQZDJYKL-UHFFFAOYSA-N octyl 18-hydroxyoctadecanoate Chemical compound CCCCCCCCOC(=O)CCCCCCCCCCCCCCCCCO PVRKSMXQZDJYKL-UHFFFAOYSA-N 0.000 description 6
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 6
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 5
- 229940048851 CETYL RICINOLEATE Drugs 0.000 description 5
- 229940015001 Glycerin Drugs 0.000 description 5
- 210000004209 Hair Anatomy 0.000 description 5
- 229940067606 Lecithin Drugs 0.000 description 5
- 239000004698 Polyethylene (PE) Substances 0.000 description 5
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical class CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 239000000969 carrier Substances 0.000 description 5
- 229960000541 cetyl alcohol Drugs 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- XAMHKORMKJIEFW-AYTKPMRMSA-N hexadecyl (Z,12R)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/C[C@H](O)CCCCCC XAMHKORMKJIEFW-AYTKPMRMSA-N 0.000 description 5
- 235000010445 lecithin Nutrition 0.000 description 5
- 239000000787 lecithin Substances 0.000 description 5
- 239000000155 melt Substances 0.000 description 5
- 229910052618 mica group Inorganic materials 0.000 description 5
- 238000004806 packaging method and process Methods 0.000 description 5
- 235000019271 petrolatum Nutrition 0.000 description 5
- 229920000573 polyethylene Polymers 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- WCOXQTXVACYMLM-UHFFFAOYSA-N 2,3-bis(12-hydroxyoctadecanoyloxy)propyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC(O)CCCCCC)COC(=O)CCCCCCCCCCC(O)CCCCCC WCOXQTXVACYMLM-UHFFFAOYSA-N 0.000 description 4
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 4
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-α-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 4
- UQEAIHBTYFGYIE-UHFFFAOYSA-N Hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 4
- XUGNVMKQXJXZCD-UHFFFAOYSA-N Isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 4
- 150000001204 N-oxides Chemical class 0.000 description 4
- 229940053207 Niacin Drugs 0.000 description 4
- MVQVNTPHUGQQHK-UHFFFAOYSA-N Nicotinyl alcohol Chemical compound OCC1=CC=CN=C1 MVQVNTPHUGQQHK-UHFFFAOYSA-N 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N Palmitic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 229920001083 Polybutene Polymers 0.000 description 4
- RUOJZAUFBMNUDX-UHFFFAOYSA-N Propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 4
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 4
- 229940057400 TRIHYDROXYSTEARIN Drugs 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
- 239000003906 humectant Substances 0.000 description 4
- 229940075495 isopropyl palmitate Drugs 0.000 description 4
- 239000010445 mica Substances 0.000 description 4
- 239000004200 microcrystalline wax Substances 0.000 description 4
- 235000019808 microcrystalline wax Nutrition 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 4
- 239000012188 paraffin wax Substances 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- BFZNCPXNOGIELB-UHFFFAOYSA-N propan-2-yl 10-[5,6-dihexyl-2-(8-oxo-8-propan-2-yloxyoctyl)cyclohex-3-en-1-yl]dec-9-enoate Chemical compound CCCCCCC1C=CC(CCCCCCCC(=O)OC(C)C)C(C=CCCCCCCCC(=O)OC(C)C)C1CCCCCC BFZNCPXNOGIELB-UHFFFAOYSA-N 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 239000000454 talc Substances 0.000 description 4
- 235000012222 talc Nutrition 0.000 description 4
- 229910052623 talc Inorganic materials 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 3
- CZBZUDVBLSSABA-UHFFFAOYSA-N Butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 3
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 3
- 229940073532 Candelilla Wax Drugs 0.000 description 3
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical group CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 3
- 241001553290 Euphorbia antisyphilitica Species 0.000 description 3
- IUJAMGNYPWYUPM-UHFFFAOYSA-N Hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 3
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 3
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 3
- ZLNQQNXFFQJAID-UHFFFAOYSA-L Magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 3
- ALSTYHKOOCGGFT-KTKRTIGZSA-N Oleyl alcohol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 3
- 239000004264 Petrolatum Substances 0.000 description 3
- 229940066842 Petrolatum Drugs 0.000 description 3
- 229940057007 Petroleum distillate Drugs 0.000 description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N Phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 3
- 229960005323 Phenoxyethanol Drugs 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N Stearyl alcohol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 229930003270 Vitamin B Natural products 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- NNCOOIBIVIODKO-UHFFFAOYSA-N aluminum;hypochlorous acid Chemical compound [Al].ClO NNCOOIBIVIODKO-UHFFFAOYSA-N 0.000 description 3
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 239000004204 candelilla wax Substances 0.000 description 3
- 235000013868 candelilla wax Nutrition 0.000 description 3
- 125000004432 carbon atoms Chemical group C* 0.000 description 3
- 239000004203 carnauba wax Substances 0.000 description 3
- 235000013869 carnauba wax Nutrition 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 229940008099 dimethicone Drugs 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- WUKXMJCZWYUIRZ-UHFFFAOYSA-N hexadecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(C)O WUKXMJCZWYUIRZ-UHFFFAOYSA-N 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 229940119170 jojoba wax Drugs 0.000 description 3
- 239000001095 magnesium carbonate Substances 0.000 description 3
- 239000011776 magnesium carbonate Substances 0.000 description 3
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 3
- VZCYOOQTPOCHFL-UPHRSURJSA-L maleate(2-) Chemical compound [O-]C(=O)\C=C/C([O-])=O VZCYOOQTPOCHFL-UPHRSURJSA-L 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 235000010446 mineral oil Nutrition 0.000 description 3
- 229940055577 oleyl alcohol Drugs 0.000 description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-M palmitate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 3
- 239000003209 petroleum derivative Substances 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000002829 reduced Effects 0.000 description 3
- 230000002441 reversible Effects 0.000 description 3
- 229920002545 silicone oil Polymers 0.000 description 3
- 239000003549 soybean oil Substances 0.000 description 3
- 235000012424 soybean oil Nutrition 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N titanium dioxide Inorganic materials O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- 239000003643 water by type Substances 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-Dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 2
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 2
- USSFUVKEHXDAPM-UHFFFAOYSA-N 3-carbamoylpyridin-1-ium-1-olate Chemical compound NC(=O)C1=CC=C[N+]([O-])=C1 USSFUVKEHXDAPM-UHFFFAOYSA-N 0.000 description 2
- 229960000458 Allantoin Drugs 0.000 description 2
- VLPFTAMPNXLGLX-UHFFFAOYSA-N Axona Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- 229940043253 Butylated Hydroxyanisole Drugs 0.000 description 2
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- 210000004709 Eyebrows Anatomy 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 229940100554 ISONONYL ISONONANOATE Drugs 0.000 description 2
- OYHQOLUKZRVURQ-UHFFFAOYSA-N Linoleic acid Chemical compound CCCCCC=CCC=CCCCCCCCC(O)=O OYHQOLUKZRVURQ-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N Linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N Methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- ZBSGKPYXQINNGF-UHFFFAOYSA-N N-nicotinoylglycine Chemical compound OC(=O)CNC(=O)C1=CC=CN=C1 ZBSGKPYXQINNGF-UHFFFAOYSA-N 0.000 description 2
- 210000000282 Nails Anatomy 0.000 description 2
- XJLXINKUBYWONI-NNYOXOHSSA-N Nicotinamide adenine dinucleotide phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-N 0.000 description 2
- 229940057874 PHENYL TRIMETHICONE Drugs 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 229940101267 Panthenol Drugs 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 241000048284 Potato virus P Species 0.000 description 2
- 229940005550 Sodium alginate Drugs 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- ABTZKZVAJTXGNN-UHFFFAOYSA-N Stearyl heptanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCC ABTZKZVAJTXGNN-UHFFFAOYSA-N 0.000 description 2
- 241000669244 Unaspis euonymi Species 0.000 description 2
- 230000036462 Unbound Effects 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 229940046009 Vitamin E Drugs 0.000 description 2
- 229960001296 Zinc Oxide Drugs 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229960001452 alpha-Tocopherol Acetate Drugs 0.000 description 2
- MHCAFGMQMCSRGH-UHFFFAOYSA-N aluminum;hydrate Chemical compound O.[Al] MHCAFGMQMCSRGH-UHFFFAOYSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229910052788 barium Inorganic materials 0.000 description 2
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium(0) Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 229940116224 behenate Drugs 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-M behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC([O-])=O UKMSUNONTOPOIO-UHFFFAOYSA-M 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 229940086555 cyclomethicone Drugs 0.000 description 2
- 229940031578 diisopropyl adipate Drugs 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 125000005908 glyceryl ester group Chemical group 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 229940049918 linoleate Drugs 0.000 description 2
- 239000007934 lip balm Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 230000003020 moisturizing Effects 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000020957 pantothenol Nutrition 0.000 description 2
- 239000011619 pantothenol Substances 0.000 description 2
- 229920000223 polyglycerol Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M propionate Chemical class CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 231100000489 sensitizer Toxicity 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 239000004945 silicone rubber Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000015424 sodium Nutrition 0.000 description 2
- MSXHSNHNTORCAW-UHFFFAOYSA-M sodium 3,4,5,6-tetrahydroxyoxane-2-carboxylate Chemical compound [Na+].OC1OC(C([O-])=O)C(O)C(O)C1O MSXHSNHNTORCAW-UHFFFAOYSA-M 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- MAKUBRYLFHZREJ-JWBQXVCJSA-M sodium;(2S,3S,4R,5R,6R)-3-[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylate Chemical compound [Na+].CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@H](O)[C@H]1O MAKUBRYLFHZREJ-JWBQXVCJSA-M 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 229940098758 stearyl heptanoate Drugs 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 235000010965 sucrose esters of fatty acids Nutrition 0.000 description 2
- 239000001959 sucrose esters of fatty acids Substances 0.000 description 2
- 230000000475 sunscreen Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 235000010215 titanium dioxide Nutrition 0.000 description 2
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000000261 vasodilator Effects 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 150000003712 vitamin E derivatives Chemical class 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N α-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- WJNMPINWDAQWSW-UNTBIKODSA-N (12R)-12-hydroxyoctadec-9-enoic acid;propane-1,2-diol Chemical compound CC(O)CO.CCCCCC[C@@H](O)CC=CCCCCCCCC(O)=O WJNMPINWDAQWSW-UNTBIKODSA-N 0.000 description 1
- WFXHUBZUIFLWCV-UHFFFAOYSA-N (2,2-dimethyl-3-octanoyloxypropyl) octanoate Chemical compound CCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCC WFXHUBZUIFLWCV-UHFFFAOYSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2R,3R,4S,5R,6S)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2S,3R,4S,5R,6R)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4S,5R,6R)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- GYDYJUYZBRGMCC-INIZCTEOSA-N (2S)-2-amino-6-(dodecanoylamino)hexanoic acid Chemical compound CCCCCCCCCCCC(=O)NCCCC[C@H](N)C(O)=O GYDYJUYZBRGMCC-INIZCTEOSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- ZNSIOEUWGZNHAQ-UHFFFAOYSA-N (3E)-N-diazoniopyridine-3-carboximidate Chemical compound [N-]=[N+]=NC(=O)C1=CC=CN=C1 ZNSIOEUWGZNHAQ-UHFFFAOYSA-N 0.000 description 1
- WSWCOQWTEOXDQX-MQQKCMAXSA-M (E,E)-sorbate Chemical compound C\C=C\C=C\C([O-])=O WSWCOQWTEOXDQX-MQQKCMAXSA-M 0.000 description 1
- LVRFTAZAXQPQHI-RXMQYKEDSA-N (R)-2-hydroxy-4-methylpentanoic acid Chemical compound CC(C)C[C@@H](O)C(O)=O LVRFTAZAXQPQHI-RXMQYKEDSA-N 0.000 description 1
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N 1-Hexanol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- AZXGXVQWEUFULR-UHFFFAOYSA-N 2',4',5',7'-tetrabromofluorescein Chemical compound OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 AZXGXVQWEUFULR-UHFFFAOYSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N 2,2-bis(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- VUCDIRJQEQYQRN-UHFFFAOYSA-N 2-(carboxymethylamino)-3-sulfanylpropanoic acid Chemical compound OC(=O)CNC(CS)C(O)=O VUCDIRJQEQYQRN-UHFFFAOYSA-N 0.000 description 1
- AFENDNXGAFYKQO-UHFFFAOYSA-N 2-Hydroxybutyric acid Chemical compound CCC(O)C(O)=O AFENDNXGAFYKQO-UHFFFAOYSA-N 0.000 description 1
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-Methyl-2,4-pentanediol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-Methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- VUKAUDKDFVSVFT-UHFFFAOYSA-N 2-[6-[4,5-bis(2-hydroxypropoxy)-2-(2-hydroxypropoxymethyl)-6-methoxyoxan-3-yl]oxy-4,5-dimethoxy-2-(methoxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)-5-methoxyoxane-3,4-diol Chemical compound COC1C(OC)C(OC2C(C(O)C(OC)C(CO)O2)O)C(COC)OC1OC1C(COCC(C)O)OC(OC)C(OCC(C)O)C1OCC(C)O VUKAUDKDFVSVFT-UHFFFAOYSA-N 0.000 description 1
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 1
- ZQZAHPFFZWEUCL-UHFFFAOYSA-N 2-chloropyridine-3-carboxamide Chemical compound NC(=O)C1=CC=CN=C1Cl ZQZAHPFFZWEUCL-UHFFFAOYSA-N 0.000 description 1
- JKRDADVRIYVCCY-UHFFFAOYSA-N 2-hydroxyoctanoic acid Chemical compound CCCCCCC(O)C(O)=O JKRDADVRIYVCCY-UHFFFAOYSA-N 0.000 description 1
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 1
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 1
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methylpentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 1
- DQAKJEWZWDQURW-UHFFFAOYSA-N 2-oxopyrrolidine-1-carboxylic acid Chemical compound OC(=O)N1CCCC1=O DQAKJEWZWDQURW-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- WYKHFQKONWMWQM-UHFFFAOYSA-N 2-sulfanylidene-1H-pyridine-3-carboxylic acid Chemical compound OC(=O)C1=CC=CN=C1S WYKHFQKONWMWQM-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K 2qpq Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- CNQCWYFDIQSALX-UHFFFAOYSA-N 3-(chloromethyl)pyridine Chemical compound ClCC1=CC=CN=C1 CNQCWYFDIQSALX-UHFFFAOYSA-N 0.000 description 1
- OSMAGAVKVRGYGR-UHFFFAOYSA-N 3-methylpyridine-4-carboxylic acid Chemical compound CC1=CN=CC=C1C(O)=O OSMAGAVKVRGYGR-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-Aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- CWSZBVAUYPTXTG-UHFFFAOYSA-N 5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)OCCO)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 CWSZBVAUYPTXTG-UHFFFAOYSA-N 0.000 description 1
- ZLWYEPMDOUQDBW-UHFFFAOYSA-N 6-aminonicotinamide Chemical compound NC(=O)C1=CC=C(N)N=C1 ZLWYEPMDOUQDBW-UHFFFAOYSA-N 0.000 description 1
- IJXDURUAYOKSIS-UHFFFAOYSA-N 6-methylpyridine-3-carboxamide Chemical compound CC1=CC=C(C(N)=O)C=N1 IJXDURUAYOKSIS-UHFFFAOYSA-N 0.000 description 1
- 229940116904 ANTIINFLAMMATORY THERAPEUTIC RADIOPHARMACEUTICALS Drugs 0.000 description 1
- 229940070312 ARACHIDYL PROPIONATE Drugs 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229940061720 Alpha Hydroxy Acids Drugs 0.000 description 1
- PZZYQPZGQPZBDN-UHFFFAOYSA-N Aluminium silicate Chemical class O=[Al]O[Si](=O)O[Al]=O PZZYQPZGQPZBDN-UHFFFAOYSA-N 0.000 description 1
- 229940063655 Aluminum stearate Drugs 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 229940095259 Butylated Hydroxytoluene Drugs 0.000 description 1
- 229940049297 CETYL ACETATE Drugs 0.000 description 1
- 240000000218 Cannabis sativa Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate dianion Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229940075510 Carbopol 981 Drugs 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229940113118 Carrageenan Drugs 0.000 description 1
- 229940106189 Ceramides Drugs 0.000 description 1
- 229940107161 Cholesterol Drugs 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N Chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 229940001468 Citrate Drugs 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 240000003412 Copernicia prunifera Species 0.000 description 1
- 235000010919 Copernicia prunifera Nutrition 0.000 description 1
- JYGXADMDTFJGBT-VWUMJDOOSA-N Cortisol Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Chemical class CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 210000003298 Dental Enamel Anatomy 0.000 description 1
- 229960003949 Dexpanthenol Drugs 0.000 description 1
- DOIRQSBPFJWKBE-UHFFFAOYSA-N Dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 1
- ORAWFNKFUWGRJG-UHFFFAOYSA-N Docosanamide Chemical compound CCCCCCCCCCCCCCCCCCCCCC(N)=O ORAWFNKFUWGRJG-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- LZCLXQDLBQLTDK-UHFFFAOYSA-N Ethyl lactate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 210000000720 Eyelashes Anatomy 0.000 description 1
- 229940100608 GLYCOL DISTEARATE Drugs 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 240000002883 Ginkgo biloba Species 0.000 description 1
- RBNPOMFGQQGHHO-UHFFFAOYSA-N Glyceric acid Chemical compound OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 1
- 229940100242 Glycol Stearate Drugs 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N Glycol stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- 229960004198 Guanidine Drugs 0.000 description 1
- 229940049290 HYDROGENATED COCO-GLYCERIDES Drugs 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229940078546 ISOEICOSANE Drugs 0.000 description 1
- 229940089456 ISOPROPYL STEARATE Drugs 0.000 description 1
- 229960005436 Inositol nicotinate Drugs 0.000 description 1
- MFZCIDXOLLEMOO-GYSGTQPESA-N Inositol nicotinate Chemical compound O([C@H]1[C@@H]([C@H]([C@@H](OC(=O)C=2C=NC=CC=2)[C@@H](OC(=O)C=2C=NC=CC=2)[C@@H]1OC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)C(=O)C1=CC=CN=C1 MFZCIDXOLLEMOO-GYSGTQPESA-N 0.000 description 1
- TWBYWOBDOCUKOW-UHFFFAOYSA-N Isonicotinic acid Chemical compound OC(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-N 0.000 description 1
- AXISYYRBXTVTFY-UHFFFAOYSA-N Isopropyl myristate Chemical compound CCCCCCCCCCCCCC(=O)OC(C)C AXISYYRBXTVTFY-UHFFFAOYSA-N 0.000 description 1
- 229940001447 Lactate Drugs 0.000 description 1
- 240000001422 Laurus nobilis Species 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 229960004488 Linolenic Acid Drugs 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 229940114937 MICROCRYSTALLINE WAX Drugs 0.000 description 1
- 229940078812 MYRISTYL MYRISTATE Drugs 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N Maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N Mandelic acid Chemical compound OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 210000004400 Mucous Membrane Anatomy 0.000 description 1
- 229940105132 Myristate Drugs 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- JRFKIOFLCXKVOT-UHFFFAOYSA-N N-(hydroxymethyl)pyridine-3-carboxamide Chemical compound OCNC(=O)C1=CC=CN=C1 JRFKIOFLCXKVOT-UHFFFAOYSA-N 0.000 description 1
- JIAOUYONZMRJJD-UHFFFAOYSA-N N-benzylpyridine-3-carboxamide Chemical compound C=1C=CN=CC=1C(=O)NCC1=CC=CC=C1 JIAOUYONZMRJJD-UHFFFAOYSA-N 0.000 description 1
- ZXOAHASJYIUCBG-UHFFFAOYSA-N N-ethylpyridine-3-carboxamide Chemical compound CCNC(=O)C1=CC=CN=C1 ZXOAHASJYIUCBG-UHFFFAOYSA-N 0.000 description 1
- NYQXIOZBHWFCBU-UHFFFAOYSA-N N-phenylpyridine-3-carboxamide Chemical compound C=1C=CN=CC=1C(=O)NC1=CC=CC=C1 NYQXIOZBHWFCBU-UHFFFAOYSA-N 0.000 description 1
- NOIIUHRQUVNIDD-UHFFFAOYSA-N Nialamide Chemical compound C=1C=CC=CC=1CNC(=O)CCNNC(=O)C1=CC=NC=C1 NOIIUHRQUVNIDD-UHFFFAOYSA-N 0.000 description 1
- 229960003057 Nialamide Drugs 0.000 description 1
- RSKQGBFMNPDPLR-UHFFFAOYSA-N Niaprazine Chemical compound C=1C=CN=CC=1C(=O)NC(C)CCN(CC1)CCN1C1=CC=C(F)C=C1 RSKQGBFMNPDPLR-UHFFFAOYSA-N 0.000 description 1
- 229940101270 Nicotinamide adenine dinucleotide (NAD) Drugs 0.000 description 1
- 206010029400 Nicotinic acid deficiency Diseases 0.000 description 1
- 229960004738 Nicotinyl Alcohol Drugs 0.000 description 1
- ZYVXHFWBYUDDBM-UHFFFAOYSA-N Nicotinyl methylamide Chemical compound CNC(=O)C1=CC=CN=C1 ZYVXHFWBYUDDBM-UHFFFAOYSA-N 0.000 description 1
- BRZANEXCSZCZCI-UHFFFAOYSA-N Nifenazone Chemical compound O=C1N(C=2C=CC=CC=2)N(C)C(C)=C1NC(=O)C1=CC=CN=C1 BRZANEXCSZCZCI-UHFFFAOYSA-N 0.000 description 1
- NCYVXEGFNDZQCU-UHFFFAOYSA-N Nikethamide Chemical compound CCN(CC)C(=O)C1=CC=CN=C1 NCYVXEGFNDZQCU-UHFFFAOYSA-N 0.000 description 1
- 229940074726 OPHTHALMOLOGIC ANTIINFLAMMATORY AGENTS Drugs 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl methoxycinnamate Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 229940086560 PENTAERYTHRITYL TETRASTEARATE Drugs 0.000 description 1
- 208000002141 Pellagra Diseases 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 229920001451 Polypropylene glycol Polymers 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 241000053208 Porcellio laevis Species 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N Prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N Pyroglutamic acid Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 description 1
- 229940079889 Pyrrolidonecarboxylic Acid Drugs 0.000 description 1
- GJAWHXHKYYXBSV-UHFFFAOYSA-N Quinolinic acid Chemical compound OC(=O)C1=CC=CN=C1C(O)=O GJAWHXHKYYXBSV-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 101710024753 SERPINB14 Proteins 0.000 description 1
- 229940080350 SODIUM STEARATE Drugs 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- 229940010747 Sodium Hyaluronate Drugs 0.000 description 1
- 229940005581 Sodium Lactate Drugs 0.000 description 1
- 229940045870 Sodium Palmitate Drugs 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- NGSFWBMYFKHRBD-UHFFFAOYSA-M Sodium lactate Chemical compound [Na+].CC(O)C([O-])=O NGSFWBMYFKHRBD-UHFFFAOYSA-M 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M Sodium stearate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 229940075554 Sorbate Drugs 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 229940034610 Toothpaste Drugs 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- SHGAZHPCJJPHSC-NWVFGJFESA-N Tretinoin Chemical compound OC(=O)/C=C(\C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NWVFGJFESA-N 0.000 description 1
- 229960001727 Tretinoin Drugs 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 240000008529 Triticum aestivum Species 0.000 description 1
- 229940045136 Urea Drugs 0.000 description 1
- 229940029983 VITAMINS Drugs 0.000 description 1
- 229940045997 Vitamin A Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229940046008 Vitamin D Drugs 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 229940021016 Vitamin IV solution additives Drugs 0.000 description 1
- AVTXVDFKYBVTKR-FXSLSZKUSA-N [(3S,8S,10R,13R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] dihydrogen phosphate Chemical compound C1C=C2C[C@@H](OP(O)(O)=O)CC[C@]2(C)C2[C@@H]1C1CCC([C@H](C)CCCC(C)C)[C@@]1(C)CC2 AVTXVDFKYBVTKR-FXSLSZKUSA-N 0.000 description 1
- VRAHPESAMYMDQI-UHFFFAOYSA-N [2-hydroxy-1,3,3-tris(pyridine-3-carbonyloxymethyl)cyclohexyl]methyl pyridine-3-carboxylate Chemical compound C1CCC(COC(=O)C=2C=NC=CC=2)(COC(=O)C=2C=NC=CC=2)C(O)C1(COC(=O)C=1C=NC=CC=1)COC(=O)C1=CC=CN=C1 VRAHPESAMYMDQI-UHFFFAOYSA-N 0.000 description 1
- OCKWAZCWKSMKNC-UHFFFAOYSA-N [3-octadecanoyloxy-2,2-bis(octadecanoyloxymethyl)propyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC OCKWAZCWKSMKNC-UHFFFAOYSA-N 0.000 description 1
- DPYOYDOVPHDRFY-UHFFFAOYSA-N [Al].[Zr].ClO.NCC(O)=O Chemical compound [Al].[Zr].ClO.NCC(O)=O DPYOYDOVPHDRFY-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 239000000980 acid dye Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001166 anti-perspirant Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000003289 ascorbyl group Chemical class [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 229940071097 ascorbyl phosphate Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 159000000009 barium salts Chemical class 0.000 description 1
- 239000000981 basic dye Substances 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- SOGAXMICEFXMKE-UHFFFAOYSA-N butyl 2-methylprop-2-enoate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N butylene glycol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229960000539 carbamide Drugs 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 150000001734 carboxylic acid salts Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007765 cera alba Substances 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 235000019480 chamomile oil Nutrition 0.000 description 1
- 239000010628 chamomile oil Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 235000019571 color Nutrition 0.000 description 1
- 230000003750 conditioning Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- RNPXCFINMKSQPQ-UHFFFAOYSA-N dicetyl hydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(=O)OCCCCCCCCCCCCCCCC RNPXCFINMKSQPQ-UHFFFAOYSA-N 0.000 description 1
- 229940093541 dicetylphosphate Drugs 0.000 description 1
- ONKUXPIBXRRIDU-UHFFFAOYSA-N diethyl decanedioate Chemical compound CCOC(=O)CCCCCCCCC(=O)OCC ONKUXPIBXRRIDU-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drugs Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 150000002194 fatty esters Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002070 germicidal Effects 0.000 description 1
- 150000002302 glucosamines Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- LSTDYDRCKUBPDI-UHFFFAOYSA-N hexadecyl acetate Chemical compound CCCCCCCCCCCCCCCCOC(C)=O LSTDYDRCKUBPDI-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 230000000774 hypoallergenic Effects 0.000 description 1
- FMXLGOWFNZLJQK-UHFFFAOYSA-N hypochlorous acid;zirconium Chemical compound [Zr].ClO FMXLGOWFNZLJQK-UHFFFAOYSA-N 0.000 description 1
- OPEHDFRKFVXKNP-UHFFFAOYSA-N icosyl propanoate Chemical compound CCCCCCCCCCCCCCCCCCCCOC(=O)CC OPEHDFRKFVXKNP-UHFFFAOYSA-N 0.000 description 1
- 230000003100 immobilizing Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- 229910000460 iron oxide Inorganic materials 0.000 description 1
- 235000013980 iron oxide Nutrition 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- 230000002427 irreversible Effects 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 230000003522 irritant Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 235000012204 lemonade/lime carbonate Nutrition 0.000 description 1
- 230000000670 limiting Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229920001684 low density polyethylene Polymers 0.000 description 1
- 239000004702 low-density polyethylene Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-L malate(2-) Chemical compound [O-]C(=O)C(O)CC([O-])=O BJEPYKJPYRNKOW-UHFFFAOYSA-L 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 description 1
- 239000002365 multiple layer Substances 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-M myristate Chemical compound CCCCCCCCCCCCCC([O-])=O TUNFSRHWOTWDNC-UHFFFAOYSA-M 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N n-pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- 150000002814 niacins Chemical class 0.000 description 1
- 229960002686 niaprazine Drugs 0.000 description 1
- 229950001071 nicomol Drugs 0.000 description 1
- 229960002187 nifenazone Drugs 0.000 description 1
- 125000005474 octanoate group Chemical class 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Chemical class [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- JYTMDBGMUIAIQH-ZPHPHTNESA-N palmityl oleate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC JYTMDBGMUIAIQH-ZPHPHTNESA-N 0.000 description 1
- SSZBUIDZHHWXNJ-UHFFFAOYSA-N palmityl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC SSZBUIDZHHWXNJ-UHFFFAOYSA-N 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001690 polydopamine Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- PBYUNDCGVVYTIG-UHFFFAOYSA-N propane-1,2-diol;tetradecyl acetate Chemical compound CC(O)CO.CCCCCCCCCCCCCCOC(C)=O PBYUNDCGVVYTIG-UHFFFAOYSA-N 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propanol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- PWHUPFOHNXWYSH-UHFFFAOYSA-N pyridin-3-ylmethylurea Chemical compound NC(=O)NCC1=CC=CN=C1 PWHUPFOHNXWYSH-UHFFFAOYSA-N 0.000 description 1
- XQWBMZWDJAZPPX-UHFFFAOYSA-N pyridine-3-carbothioamide Chemical compound NC(=S)C1=CC=CN=C1 XQWBMZWDJAZPPX-UHFFFAOYSA-N 0.000 description 1
- 239000001651 pyrus cydonia seed extract Substances 0.000 description 1
- 230000001105 regulatory Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000037335 skin penetration Effects 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- NGSFWBMYFKHRBD-UHFFFAOYSA-N sodium;2-hydroxypropanoic acid Chemical compound [Na+].CC(O)C(O)=O NGSFWBMYFKHRBD-UHFFFAOYSA-N 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000003445 sucroses Chemical class 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing Effects 0.000 description 1
- 239000003784 tall oil Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960005196 titanium dioxide Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- COXJMKGEQAWXNP-UHFFFAOYSA-N tris(14-methylpentadecyl) 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CC(C)CCCCCCCCCCCCCOC(=O)CC(O)(C(=O)OCCCCCCCCCCCCCC(C)C)CC(=O)OCCCCCCCCCCCCCC(C)C COXJMKGEQAWXNP-UHFFFAOYSA-N 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 150000004370 vitamin A ester derivatives Chemical class 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 235000021307 wheat Nutrition 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Abstract
Disclosed are cosmetic compositions, including lipsticks, comprising from 0.01%to about 50%, by weight, of cylindrical crystalline vitamin B3 particles having a particle size distribution such that at least about 70%of the crystalline particles have a height to width ratio greater than 1;from about 1%to about 90%, by weight, of an emollient component;from about 1%to about 90%, by weight, of a solidifying agent;and from about 1%to about 90%, on an anhydrous basis, of a color. The compositions provide improved skin feel of crystalline vitamin B3 compounds when applied to skin.
Description
COSMETIC COMPOSITIONS CONTAINING VITAMIN B3
FIELD OF THE INVENTION
The present invention relates to topical cosmetic compositions containing crystalline cylindrical vitamin B3 compounds.
BACKGROUND OF THE INVENTION
Niacin, also known as vitamin B3, is the common name for nicotinic acid. The physiologically active form of niacin is niacinamide, also a member of the family of vitamin B3 compounds. Niacin and niacinamide (nicotinic acid amide) function in the body as components of two coenzymes: nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP). Recently, these vitamin B3 compounds were used exclusively to treat niacin and pellagra deficiency. However, nowadays, vitamin B3 compounds have also found use in the area of active skin care. British Patent 1 370,236 discloses skin lightening compositions containing 0.5% to 10% niacin. In the same way, the patent of E.U.A. 4,096,240 describes the use of 0.1% to 10% niacinamide to lighten the skin. It has also been found that vitamin B3 compounds are useful for regulating the texture of human skin. See PCT application WO 97/39733, for Oblong et al. However, when applied to the skin in crystalline (i.e., powder) form, the vitamin B3 compounds tend to give a rough feeling to the skin. In the past, crystalline vitamin B3 compounds were solubilized in a polar solvent before application to the skin, destroying the crystalline structure and thus alleviating the rough sensation of the crystals. However, solubilization reduced the efficacy of the vitamin B3 compound at the time of contact with the skin. Thus, there is a need for cosmetic compositions comprising the non-solubilized crystalline vitamin B3 compound (s) which provides an improved skin feel that the consumer can sense. The present inventors have discovered that cosmetic formulations incorporating crystalline vitamin B3 compounds of a specific crystalline structure and an emollient improve the sensation perceived by the consumer of the vitamin B3 compound in the skin. The inventors of the present invention have further discovered that these compositions are especially useful for providing the benefits of vitamin B3 to the lips with improved skin feel when used in lipstick compositions including a solidifying agent. It is, therefore, an aspect of the present invention to provide cosmetic compositions, preferably anhydrous cosmetic compositions, which comprise selecting crystalline structured vitamin B3 compounds that improve the appearance and feel of the skin while alleviating the harsh feeling of the crystalline vitamin B3 compound. . Another aspect of the present invention is to provide anhydrous cosmetic compositions comprising vitamin B3 compounds of selected crystal structure that improve the feel of the vitamin B3 compound in the skin. These and other aspects will be readily apparent from the following detailed description.
BRIEF DESCRIPTION OF THE INVENTION
The present invention relates to cosmetic compositions providing improved skin feel, containing from about 0.01% to about 50%, by weight, of the crystalline cylindrical vitamin B3 compound particles having a particle size distribution of so that at least about 70% of the crystalline particles have a height to width ratio greater than 1; from about 1% to about 90%, by weight, of an emollient; from about 1% to about 90%, by weight of a solidifying agent; and from about 1% to about 90%, on an anhydrous basis, of one color. Preferably the compositions are anhydrous. The compositions of the present invention are useful for improving the skin feel that is perceived by the consumer of crystalline cylindrical vitamin B3 compounds when applied to the skin. All percentages, parts and ratios are based on the total weight of the cosmetic compositions of the present invention, unless otherwise specified. All weights, while belonging to the aforementioned ingredients, are based on the active level and, therefore, do not include carriers or by-products that may be included in commercially available materials, unless otherwise specified.
DETAILED DESCRIPTION OF THE INVENTION
As used herein, the term "cosmetics" includes makeup, make-up base, and skin care products. The term "makeup" refers to the products that give color to the face, including base for makeup, dark and tanned, that is, mascara, eyeliners, eyebrow color, eye shadows, blushes, lip colors, etc. Skin care products are those that are used to treat or care for, or in some way moisturize, improve, or cleanse the skin. Products covered by the phrase "skin care products" include, but are not limited to, adhesives, bandages, toothpaste, anhydrous occlusive humectants, laundry detergents, fabric softening towels, patches which provide occlusive drugs, antiperspirant, deodorants, nail enamels, powders, fabrics, cloths, solid emulsion compact articles, anhydrous hair conditioners, and the like. The term "foundation for makeup" refers to liquids, cream, foam, powder, or similar products created or reintroduced by cosmetic companies to match the overall color of the skin. The base for makeup is made to work better on moisturized and / or oily skin. As used herein, the term "comprises" means that the composition may contain other ingredients that are compatible with the composition and that preferably do not substantially disrupt the compositions of the present invention. The term includes the terms "consists of" and "consists essentially of".
ESSENTIAL COMPONENTS
Vitamin B Compound The compositions of the present invention comprise a safe and effective amount of a natural or synthetic cylindrical crystalline vitamin B3 compound. The compositions of the present invention preferably comprise from above 0.01% to about 50%, more preferably from about 0.1% to about 30%, even more preferably from 0.5% to about 20%, more preferably from about 1% to about 10%. % of the vitamin B3 compound.
As used herein, "vitamin B3 compound" means a compound having the formula:
wherein R is -CONH2 (for example, niacinamide), -COOH (for example, nicotinic acid) or -CH2OH (for example, nicotinyl alcohol), derivatives thereof and salts of any of the above. Examples of derivatives of these vitamin B3 compounds as used herein include vitamin B3 derivatives known in the art, such as nicotinic acid ethers, including non-vasodilating esters of nicotinic acid, nicotinic amino acids, acid nicotinyl alcohol esters carboxylic acids, and also nicotinic acid N-oxide and niacinamide N-oxide are included. Suitable nicotinic acid esters include nicotinic acid esters of C 1 -C 22, preferably C 1 -C 16, more preferably C 1 -C 2 alcohols. The alcohols are suitably straight chain or branched chain, cyclic or acyclic, saturated or unsaturated (including aromatic), and substituted or unsubstituted. The esters are preferably non-blushing. As used herein "non-blushing" means that the ester does not commonly produce a visible flow response after application to the skin of the target compositions (the majority of the general population does not experience a visible flow response, although said compounds can cause the swimming vasodium not visible to the exposed eye). Alternatively, a nicotinic acid material that is vasodilator in high doses can be used in a lower dose to reduce the vasodilator effect. Non-vasodilating esters of nicotinic acid include tocopherol nicotinate and inositol hexanicotinate. Other derivatives of the vitamin B3 compound are the niacinamide derivatives that result from the substitution of one or more of the hydrogens of the amide group. Non-limiting examples of niacinamide derivatives useful herein include nicotinyl amino acids, derived, for example, from the reaction of an activated nicotinic acid compound (e.g., nicotinic acid azide or nicotinyl chloride) with an amino acid, and nicotinyl alcohol esters of organic carboxylic acids (e.g., C? -C ? s). Specific examples of such derivatives include nicotinuric acid having the following chemical structures: nicotinuric acid:
Examples of nicotinyl alcohol esters include nicotinyl alcohol esters of carboxylic acids, salicylic acid, acetic acid, glycolic acid, palmitic acid, and the like. Other non-limiting examples of the vitamin B3 compounds useful herein are 2-chloronicotinamide, 6-aminonicotinamide, 6-methylnicotinamide, n-methyl-nicotinamide, n, n-diethylnicotinamide, n- (hydroxymethyl) -nicotinamide, quinolinic acid, nicotinanilide, n-benzylnicotinamide, n-ethylnicotinamide, nifenazone, nicotinaldheido, isonicotinic acid, methylisonicotinic acid, thionicotinamide, nialamide, 1- (3-pyridylmethyl) urea, 2-mercaptonicotinic acid, nicomol, and niaprazine. Examples of the above vitamin B3 compounds are well known in the art and are commercially available from a number of sources, for example, the Sigma Chemical Company (St. Louis, MO); ICN Biomedicals, Inc. (Irvin, CA) and the Aldrich Chemical Company (Milwaukee, Wl). One or more vitamin B3 compounds can be used herein. Preferred compounds of vitamin B3 are nicotinic acid, niacinamide, tocopherol nicotinate, nicotinic acid N-oxide and niacinamide N-oxide. Niacinamide is the most preferred. The salts of the vitamin B3 compound are also useful herein. Non-limiting examples of salts of the vitamin B3 compound useful herein include organic or inorganic salts, such as inorganic salts with anionic inorganic species (eg, chloride, bromide, iodide, carbonate, preferably chloride), and carboxylic acid salts organic (including mono-, di- and tricarboxylic acid salts of C1-C18, for example, acetate, salicylate, glycolate, lactate, malate, citrate, preferably salts of monocarboxylic acid such as acetate). These and other salts of the vitamin B3 compound can be easily prepared by the person skilled in the art, for example, as described by W. Wenner, "The Reaction of L-Ascorbic and D-lsoascorbic Acid with Nicotinic Acid and Its Amide" , J. Organic Chemistry, Vol. 14, 22-26 (1949), which is incorporated herein by reference. Wenner describes the synthesis of the ascorbic acid salt of niacinamide. When used, the salts, derivatives, and derivatives of niacinamide salts are preferably those which have substantially the same efficacy as niacinamide in the skin condition regulation methods described herein. In a preferred embodiment, the ring nitrogen of the vitamin B3 compound is chemically free substantially (for example unbound and / or unimpeded), or after delivery to the skin chemically becomes substantially free ("chemically free"). "hereinafter referred to alternatively as" without complex "). More preferably, the vitamin B3 compound is essentially without complex. Therefore, if the composition contains the vitamin B3 compound in a salt or other form with complex, said complex preferably is substantially reversible, more preferably essentially reversible, in the delivery of the composition to the skin. For example, said complex must be substantially reversible at a pH of about 5.0 to about 6.0. Said reversibility can be easily determined by the person skilled in the art.
More preferably, the vitamin B3 compound is substantially free of complex in the composition prior to delivery to the skin. Examples of approaches to minimize or avoid the formation of undesirable complexes include the omission of materials whose form is substantially irreversible or other complexes with the vitamin B3 compound, pH adjustment, ionic strength adjustment, the use of surfactants, and formulations in where the vitamin B3 compound and materials whose complex therein is in different phases. Such approaches are within the skill level of the person skilled in the art. In this way, in a preferred embodiment, the vitamin B3 compound contains a limited amount of the salt form and is more preferably free of salts in substantial form of a vitamin B3 compound. Preferably the vitamin B3 compound contains less than about 50% of said salt, and more preferably essentially free of the salt form. The vitamin B3 compound in the compositions herein has a pH of about 4 to about 7 which typically contains less than about 50% of the salt form. The vitamin B3 compound can be included as the substantially pure material, or as an extract obtained by adequate physical and / or chemical isolation from natural sources (e.g., plants). The vitamin B3 compound is preferably substantially pure, more preferably essentially pure.
The vitamin B3 compounds of the present invention comprise cylindrical crystalline particles having a particle size distribution such that at least about 70% of the crystalline particles have a height to width ratio greater than 1 or about 1, preferably at least about 70% of the crystalline particles have a height-to-width ratio greater than 1.5 or about 1.5, more preferably at least about 50% of the crystalline particles have a height-to-width ratio greater than 2 or about 2. Preferably, the particles of Vitamin B3 crystals have a mean main particle size length of about 0.01 μm (microns) to about 200 μm, preferably from about 0.01 μm to about 100 μm, more preferably from about 0.01 μm to about 50 μm, more preferably from about 0.01 μm to about 20 m. Preferably, the vitamin B3 compounds have a particle size distribution such that at least about 60% of the vitamin B3 particles are less than about 30 μm, more preferably at least about 75% of the vitamin B particles are smaller that about 30 μm, more preferably at least about 85% of the vitamin B3 particles are less than about 30 μm, still more preferably at least about 90% of the vitamin B3 particles are less than about 30 μm in length. Enhanced vitamin B3 compound crystals can be prepared by dissolving the crude or pure vitamin B3 compound in a suitable solvent and recrystallizing the compound using any of a variety of conventional crystallization techniques, however the preparation is not limited to this method. Such crystallization techniques include, but are not limited to, evaporation from a single solvent, evaporation from a mixture of binary solvents (volatile solvent and non-volatile solvent), intermittent crystallization, liquid-liquid diffusion, phase diffusion. settled droplet vapor, vapor phase diffusion of drop pending, temperature change, solidification and sublimation by gel crystallization. These crystallization techniques are described in greater detail in Van der Sluis, P., Hezemans, A.M.F., and Kroon, J, Crystallization of Low-Molecular-Weight Organic Compounds for X-ray Crystallization, J. Appl. Cryst. (1989) .22, 340-344 and Alexander McPherson, Preparation and Analysis of Protein Crystals, Robert E. Krieger Publishing Co. (1989), both are incorporated herein in their entirety.
Emollient Compound The compositions of the present invention further comprise an emollient suitable for suspending or otherwise dispersing the crystalline vitamin B3 compound therein. Any emollient that is known or otherwise suitable for use in cosmetic applications, and that is also compatible with the cylindrical crystalline vitamin B3 compound in the composition, can be used in the composition of the present invention. Preferred emollients for use in the composition of the present invention are those materials that are mentioned in personal care techniques such as fats, oils, fatty alcohols, fatty acids, fatty acid esters, and combinations thereof, and which they help in the application and adhesion, produce shine and / or provide occlusive wetting. The emollient component comprises from about 1% to about 90%, preferably from about 10% to about 80%, more preferably from about 20% to about 70%, and more preferably from about 40%, to about 60% OF THE COSMETIC COMPOSITION Emollients suitable for use in the present invention include derivatives of isostearic acid, isopropyl palmitate, lanolin oil, diisopropyl dimerate, maleate soybean oil, octyl palmitate, isopropyl isostearate, cetyl lactate, cetyl ricinoleate, tocopheryl acetate, acetylated lanolin alcohol, cetyl acetate, phenyltrimethicone, glyceryl oleate, tocopheryl linoleate, wheat germ glycerides, arachidyl propionate, myristyl lactate, decyl oleate, propylene glycol ricinoleate, isopropyl lanolate, pentaerythrityl tetrastearate, neopentyl glycol dicaprylate / dicaprate, hydrogenated cocoglycerides, isononyl isononanoate, isotridecyl isononanoate, myristyl myristate, triisocetyl citrate, cetyl alcohol, octyl dodecanol, oleyl alcohol, panthenol, lanolin alcohol, linoleic acid, linolenic acid, sucrose esters of fatty acids, octyl hydroxystearate and mixtures thereof. Examples of other suitable emollients are described in Cosmetic Bench Reference, pp. 1.19-1.22 (1996), whose descriptions are incorporated herein by reference. For use herein, non-polar emollients are particularly preferred. "Non-polar emollients", as used herein, means any emollient emulsifier that does not possess permanent electric moments and wherein the solubility (at 30 ° C) of the vitamin B3 compound is in the polar emollient and is less than about 1.5%, preferably less than about 1.0%, more preferably less than about 0.5%. Suitable non-polar emollients include, but are not limited to, esters and straight chain or branched hydrocarbons. Non-limiting examples of such emollients are isononyl isononanoate, isopropyl isostearate, octyl hydroxystearate, diisopropyl dimerate, lanolin oil, octyl palmitate, isopropyl palmitate, paraffins, isoparaffins, acetylated lanolin, sucrose fatty acid esters, myristate of isopropyl, isopropyl stearate, mineral oil, silicone oils, dimethicone, allantoin, isohexadecane, isododecane, petrolatum and mixtures thereof. As used herein, the solubility of the vitamin B3 compound in non-polar emollients is determined by means of the methodology described below. Suitable oil emollients for use in the compositions of the present invention include esters, triglycerides, hydrocarbons and silicones. These can be a single material or a mixture of one or more materials. They will usually comprise from about 1% to about 100%, preferably from about 5% to about 90%, and more preferably from about 70% to about 90% of the emollient component. The oils act as emollients and may also provide viscosity, tackiness, and entrainment properties to cosmetic compositions such as lipsticks. Examples of suitable oils include caprylic triglycerides, capric triglyceride, isostearic triglyceride; adipic triglyceride; Propylene glycol myristyl acetate; lanolin; lanolin oil; polybutene, sopropyl palmitate; isopropyl myristate; isopropyl isostearate; Diethyl sebacate; diisopropyl adipate; tocopheryl acetate; tocopheryl linoleate; hexadecyl stearate; ethyl lactate; cetyl oleate; cetyl ricinoleate; oleyl alcohol; hexadecyl alcohol; octyl hydroxystearate; octyl dodecanol; wheat germ oil; hydrogenated vegetable oils; Castor oil; • petrolatum; modified lanolins; branched chain hydrocarbons; alcohols and esters; corn oil; cottonseed oil; olive oil; palm kernel oil; rapeseed oil; safflower oil; jojoba oil; ass grass oil; mineral oil of avocado oil; yellow or white butter, octylpalmitate, soybean oil with maleate; glycerol trioctanoate, diisopropyl dimerate, and volatile and non-volatile silicone oils including phenyl trimethicone. Preferred oils for use herein are acetyglycerides, octanoates and decanoates of alcohols and polyalcohols, such as glycol and glycerol, the ricinoleates of alcohols and polyalcohols such as cetyl ricinoleate, PG-3 distearate, polyglycerol ethers, polyglycerol esters, triglycerides caprylics, capric triglycerides, isostearic triglyceride, adipic triglyceride, phenyl timethicone, lanolin oil, polybutene, isopropyl palmitate, isopropyl isostearate, cetyl ricinoleate, octyl dodecanol, oleyl alcohol, hydrogenated vegetable oils, castor oil, modified lanolins, octyl palmitate, lanolin oil, maleate soybean oil, cetyl ricinoleate, glyceryl trioctanoate, diisopropyl dimerate, synthetic lanolin derivatives and branched chain alcohols, sucrose esters of fatty acids, octyl hydroxystearate and mixtures thereof. Preferably, the oils used are selected so that the majority (at least about 75%, preferably at least about 80%, and more preferably at least 99%) of the types of oils used have solubility parameters that do not differ by more than about 1 to about 0.1, preferably about 0.8 to about 0.1.
OPTIONAL COMPONENTS
Solidifying Agents The cosmetic compositions of the present invention may further comprise a solidifying agent to solidify or entrap any liquid base material in the cosmetic compositions. As used herein, the term "solidify" refers to the physical and / or chemical alteration of the liquid base material to form a solid or semi-solid at ambient conditions, i.e., to form a final composition having a physical structure stable and deposit on the skin during normal conditions of use. As will be appreciated by those skilled in the art, the selection of the particular solidification agent to be used in cosmetic compositions will depend on the particular type of composition desired, ie, gel or wax-based, the desired rheology, the base material used liquid and other materials to be used in the composition. The solidifying agent is preferably present at a concentration of from about 1% to about 90%, more preferably from about 1% to about 50%, even more preferably from about 5% to about 40%, more preferably from about 3% to approximately 20%.
The wax-based cosmetic stick forms of the invention preferably contain from about 5% to about 50% (by weight) of the solidification agent with wax. The term "wax solidification agent", as used herein, refers to a solidification material having similar characteristics to wax. Said materials with wax can also serve as emollients. Among the wax materials useful herein are high melting waxes, ie, having a melting point of about 65 ° C to about 125 ° C, such as beeswax, spermaceti, carnauba, laurel berry, candelilla, montan, ozokerite, ceresin, paraffin, synthetic waxes such as waxes of Físher-Tropsch, microcrystalline wax and mixtures thereof. Ceresin, ozokerite, white beeswax, synthetic waxes, and mixtures thereof, are among the preferred high-melting waxes useful herein. The compositions having waxes, among those which are useful herein, are described in the U.S. patent. 4,049,792, Elsnau, filed September 20, 1977, incorporated herein by reference in its entirety). Low-melting waxes, having a melting point of about 37 ° C to about 75 ° C, are preferred for use in the wax-based stick embodiments of the invention. In the form of wax sticks containing volatile silicone oils as liquid base material, they preferably contain from about 10% to about 35%, more preferably from about 10% to about 20% (by weight), of a wax low melting point. Such materials include fatty acids, fatty alcohols, fatty acid esters and fatty acid amides, which have fatty chains of from about 8 to about 10 carbon atoms, and mixtures thereof. Preferred wax-like materials include cetyl alcohol, palmitic acid, stearyl alcohol, behenamide, sucrose esters of bait fatty acids, polyethylene glycol mono and digraso acid esters, and mixtures thereof. Stearyl alcohol, cetyl alcohol, and mixtures thereof, are particularly preferred. The fatty acids, fatty alcohols, and other wax-like materials useful in this invention are described in the following references, which are all incorporated herein by reference: U.S. Pat. 4,151, 272, Geary, et al., Filed April 24, 1979; patent of E.U.A. 4,229, 432, Geria, filed October 21, 1980; and patent of E.U.A. 4,280, 994, Turney, filed July 28, 1981; "The Chemistry and Technology of Waxes", A.H. Warth, second edition, reprinted in 1960, Reinhold Publishing Corporation, pp. 391-393 and 421; "The Petroleum Chemicals Industry", R.F. Goldstein and A. L. Waddeam, third edition (1967), E & F.N. Span Ltd., pp 33-40; "The Chemistry and Manufacture of Cosmetics", M.G. DeNavarre, second edition (1970), Van Nostrand & Company, pp 354-376; and in "Encyclopedia of Chemical Technology :, Vol. 24, Kirk-Othmer, Third Edition (1979) pp 466-481. Preferred wax-like materials useful as solidifying agents in the wax bars of the present are described in US Pat. US Patent 4,126,679, Davy, et al., issued November 21, 1978, which is incorporated herein in its entirety Preferred mixtures of wax-like materials comprise fatty alcohols containing carbon chains around 14 to about 18 carbon atoms, and alcohols having chain lengths of 20 carbons or more, wherein the final mixture contains from about 1% to about 3% (by weight) of the longer chain fatty alcohols. compositions containing these fatty alcohol mixtures are described in European Patent Specification No. 117,070, published August 29, 1984 (incorporated by reference herein). polymers such as those described in European application No. 522624, to Dunphy et al., incorporated herein by reference in its entirety. The gel bar embodiments of this invention preferably contain from about 3% to about 30%, preferably from about 3% to about 10% (by weight) of a solidifying agent. The particular amount of the solidifying agent to be used will depend on the particular solidifying agent and the liquid base material used, and the desired physical characteristics of the gel stick. The solidifying agents useful in the gel bar embodiment of this invention are, in general, surface active compounds that form networks by immobilizing or solidifying the liquid base materials in a gel. Such solidifying agents include: soaps, such as sodium and potassium salts of higher fatty acids, ie, acids having from 12 to 22 carbon atoms; amides of higher fatty acids; higher fatty acid amides of alkylaminos; acetals of dibenzaldehyde-monosorbitol; alkali metal salts and alkaline earth metal salts of acetates, propionates and lactates; waxes, such as candelillas and caranauba; and mixtures thereof. Among these preferred solidifying agents for use in the gel stick embodiments of this invention are sodium stearate, sodium palmitate, aluminum stearate, aluminum-magnesium hydroxystearate, and mixtures thereof. Gel stick compositions containing solidifying agents among those useful herein are described in the following patent documents, all incorporated herein by reference in their entirety: US Patent 2,900,306, Slater, issued August 18, 1959; U.A. Patent 3,255,082, Barton, issued June 7, 1966; U.A. Patent 4,137,306, Rubino et al., issued January 30, 1979; U.A. Patent 4,154,816, Roehl, et al., issued May 15, 1979; U.S. Patent No. 4,226,899, Yuhas, issued October 7, 1980; U.A. Patent 4,346,079, Roehl, issued August 24, 1982; U.A. Patent 4,383,988, Teng, et al., issued May 17, 1983; European Patent Specification No. 107,330, Luebbe, et al., published May 2, 1984; and U.S. Patent Application Serial No. 630,790, DiPietro, filed July 13, 1984. Preferred solidifying agents useful in the gel bar embodiments of the present invention are described in European Patent Specification No. 24, 365 Sampson et al., Published March 4, 1981, incorporated herein by reference in its entirety. Conventional thickeners are also useful herein as solidifying agents. Examples of suitable thickeners include, but are not limited to, natural polymeric materials such as locust bean gum, sodium alginate, sodium caffeinate, egg albumin, gelatin agar, carrageenan gum sodium alginate, xanthan gum, quince seed extract, tragacanth gum, starch, chemically modified starches and the like, semi-synthetic polymeric materials, such as cellulose ethers (for example hydroxyethylcellulose, methylcellulose, carboxymethylcellulose, hydroxypropylmethylcellulose), polyvinylpyrrolidone, polyvinyl alcohol, guar gum, hydroxypropyl guar gum, soluble starch, cationic celluloses, cationic guands and the like and synthetic polymeric materials, such as carboxyvinyl polymers, polyvinylpyrrolidone, polyvinyl alcohol of polyacrylic acid polymers, polymethacrylic acid polymers, polyvinyl acetate polymers, polyvinyl chloride polymers, polyvinylidene chloride polymers and the like. Inorganic thickeners such as aluminum silicates such as, for example, bentonites, or a mixture of polyethylene glycol and polyethylene glycol stearate or distearate can also be used. Natural polymers or biopolymers and their use, is described further in European application No. 522624, to Dunphy et al. Additional examples of natural polymers or biopolymers can be found in Cosmetic Bench Reference, pp. 1.40-1.42, which is incorporated herein by reference. Also useful are hydrophilic gelling agents such as copolymers of acrylic acid / ethyl acrylate and the carboxyvinyl polymers sold by B.F. Goodrich Company with the commercial name of Carbopol Registered TM resins. These resins consist essentially of a colloidally water-soluble polyether-polyalkenyl crosslinked polymer of acrylic acid crosslinked with 0.75% to 2.00% of an entanglement agent such as for example polyallyl sucrose or polyallyl pentaerythritol. Examples include Carbopol 934, Carbopol 940, Carbopol 950, Carbopol 980, Carbopol 951 and Carbopol 981. Carbopol 934 is a water-soluble polymer of acrylic acid crosslinked with about 1% of a polyallyl ether of sucrose having an average of about 5.8 groups allyl for each sucrose molecule. Also suitable for use herein are carbomers sold under the tradename "Carbopol Ultrez 10, Carbopol ETD2020, Carbopol 1382, Carbopol 1342 and Pemulen TR-1 (CTFA designation: Acrylates / 10-30 Alkil Acrylate Crosspolymer). of the above polymers are also useful herein Other gelling agents suitable for use herein include oleogels such as trihydroxystearin Hydrophobically modified celluloses are also useful for use herein These celluloses are described in detail in US Pat. 4,228,277 and 5,101, 646, both incorporated herein by reference in their entirety Additional examples of suitable gelling agents or gelling agents can be found in Cosmetic Bench Reference, page 1.27, which is incorporated herein by reference. the theory, it is believed that the solidifying agent in combination with the emollient, acts omo as an occlusive on the skin to form films of double layers or continuous or discontinuous multiple layers on the skin. The term "occlusive", as used herein, refers to avoiding or obstructing something, in this case, preventing the removal of moisture (by means of evaporation) and the vitamin B3 compound (by means of the link to the film) from a surface of the skin.
Color Certain embodiments of the present invention, preferably lipstick or lip paints, may further comprise from about 1% to about 90%, preferably about 1% to about 35%, more preferably from about 1% to about 20% and more preferably from about 5% to about 15% color, on a weight basis of anhydrous pigment. These are usually aluminum, barium or calcium salts or lacquers. Preferably, the dyes are present in about 0.1% to about 4% or nacre of about 0% to about 20%.
The pigments are typically dispersed in emollients to obtain a good dispersion of the pigments, when incorporated into the compositions for the lips, thus providing a uniform distribution of color. The colors / pigments suitable for use herein are all suitable inorganic and organic colors / pigments for use in lipstick compositions. Lacquers are also a pigment that is extended or reduced with a solid diluent or an organic pigment that is prepared by the precipitation of a water-soluble dye or an absorption surface, which is generally an aluminum hydrate. There is no certainty in some cases if the soluble dye is precipitated on the surface of the aluminum hydrate to produce a dyed inorganic pigment or is precipitated merely in the presence of the substrate. A lacquer is also formed from a precipitation of an insoluble salt from an acid dye or a basic dye. The calcium and barium lakes can also be used here. Lacquers suitable for use in the present invention include red aluminum lacquer 3, red aluminum lacquer 21, red aluminum lacquer 27, red aluminum lacquer 28, red aluminum lacquer 33, yellow aluminum lacquer 5, yellow aluminum lacquer 6, yellow aluminum lacquer 10, aluminum lacquer orange 5 and blue aluminum lacquer 1, red barium lacquer 6, red calcium lacquer 7.
Other colors and pigments can also be included in lipsticks such as dyes and nacres, titanium dioxides, dyes Red 6, Red 21, Brown, Berber and Siena color, lime carbonate, talcum, iron oxides and titanate micas. Dispersants can also be used together with colors and pigments of the present invention. Examples of suitable dispersants include, but are not limited to, those described in the patent of US Pat. No. 5,688,493, incorporated herein by reference in their entirety.
Dermatologically Acceptable Anhydrous Vehicle The composition of the present invention further includes a dermatologically acceptable anhydrous carrier or carrier, together with the emollient component described herein below. Said vehicle must be compatible with the skin, nails, mucous membranes, tissues and hair and includes any conventionally used cosmetic or dermatological vehicle that meets these requirements. Said vehicle must also be compatible with the crystalline vitamin B3 compound, ie the vehicle must not interact with or substantially dissolve the crystalline vitamin B3 compound. The crystalline vitamin B3 compound is preferably dispersed in the emollient component of the composition. The emollient can be part of the vehicle system. Suitable carriers in addition to the emollients described herein include, but are not limited to ointments, lipstick, foundation for makeup, mascara, powder, suspensions, creams, lotions, gels, foams, and the like. Such vehicles facilitate topical application and, in some cases, provide for additional therapeutic effects, for example, by moisturizing the affected areas of the skin. Those skilled in the art can easily select dermatologically acceptable anhydrous vehicles. Preferably, the vehicle is substantially anhydrous. In this context "substantially anhydrous" means that the vehicle provides the composition with less than 20%, preferably less than 5%, preferably less than 1%, preferably 0% free or unbound water by weight of the composition.
Substantially free of polar solvents The present invention is preferably substantially free of polar solvents. In general, "polar solvents" refer to those solvents which contain hydroxyl and / or carbonyl groups and which also have high dielectric constants and strong polarity. In general, the phrase "substantially free" means the level of said polar solvents or mixtures of polar solvents that is preferably less than about 0.5%, more preferably 0.1% and more preferably 0%. Without being limited by theory, said polar solvents tend to dissolve or otherwise interact with the crystal structure of the vitamin B3 compounds. Examples of said polar include, but are not limited to, water; alcohols, such as ethanol, propyl alcohol, isopropyl alcohol, hexanol, and benzyl alcohol; polyols, such as propylene glycol, polypropylene glycol, butylene glycol, hexylene glycol, maltitol, sorbitol, and glycerin; pentanol dissolved in glycerin; flavor oils, and mixtures thereof.
Other additives Other optional ingredients that may be present in the cosmetic compositions of the present invention include flavor oils, fat-soluble vitamins such as vitamin A and E, vitamin A esters (eg, acetate, propionate or palmitate) or vitamin E (for example, acetate or sorbate), sunscreens such as octyl methoxycinnamate, butyl methoxydibenzoylmethane, titanium dioxide and zinc oxide, germicides such as triclosan, anti-inflammatory agents such as hydrocortisone, lipid materials such as ceramides and liposomes and other assets for skin care. The cosmetic compositions may comprise ingredients conventionally employed in cosmetic compositions, such as mascara, make-up base or lip care products. This includes active ingredients for skin care, such as pharmaceutically active ingredients. The active ingredients for skin care both in water-soluble and water-insoluble form can be added to the cosmetic compositions of the present invention. These include but are not limited to vitamin C and its derivatives (e.g., ascorbyl palmitate, ascorbyl phosphate and its salts such as magnesium or sodium), vitamin D, panthenol, retinoic acid, zinc oxide, beta-glycerietic acid;
chamomile oil; ginko biloba extract; pyroglutamic acid, salts or esters; sodium hyaluronate; 2-hydroxyoctanoic acid; sulfur; salicylic acid; carboxymethylcysteine, and mixtures thereof. These additives, both fat soluble and water soluble, will be present in amounts of less than about 10% by weight, generally in the range of about 0.01% to about 5%, preferably about 0.01% about 3%, more preferably about 0.1% to about 1% by weight. Organic binders such as stearic acid, paraffin, butyl acetate, ethylene vinyl acetate copolymer, methacrylic acid butyl ester, dibutyl phthalate, polyester and mixtures thereof may be used in the present invention. Flavor oils such as peppermint oil, orange oil, citrus fruit oil, wintergreen oil, can be used together with alcohol or glycerin. Flavor oils are generally mixed in a solvent such as ethanol to dilute the flavor. The flavor oils useful herein may be derived from natural sources or may be prepared synthetically. Generally, flavor oils are mixtures of ketone, alcohols, fatty acids, esters and terpenes. The term "flavor oil" is generally recognized in the art as a liquid that is derived from botanical sources, i.e. leaves, bark, or peel of fruits or vegetables, and which are generally insoluble in water. The flavor oil used can vary from 0% to about 5%, preferably from about O.01% to about 5%, preferably from about 0.01% to about 1%. Additional humectants may also be included in the compositions of the present invention. Preferred humectants include pyrrolidone carboxylic acid, sodium lactate or lactic acid, urea, guanidine, glyceric acid and its salts (eg, calcium salt), petrolatum, collagen, ether, hydroxypropyl glyceryl, α-hydroxy acids ( for example, ethylglycolic acid, leucic acid, mandelic acid, glycolic acid), glucosamines, and elastin fibers, D-panthenol, allantoin and hyaluronic acid and chondroitin sulfate. Examples of suitable humectants can be found in Cosmetic Bench Reference, p. 1.30-1.32 (1996), which is incorporated herein by reference. Surfactants can be added to the compositions of the present invention. Suitable surfactants are those capable of forming association structures in contact with a polar solvent. Examples of said surfactants can be found in the patent of E.U.A. for 5,843, 407 to El-Nokali, which is incorporated herein by reference. When the surfactants are used, they are preferably present at a concentration of from about 0.1% to about 30%, more preferably 1% to about 15%, more preferably from about 1% to about 5% by weight of the composition.
Also useful herein are emulsifiers commonly known as binding agents. When used, the total concentration of the emulsifier can be from about 0% to about 20% of the formulation, preferably from about 0% to about 15%, more preferably from about 0.1% to about 15% and more preferably from about 1% to about 10%. Examples of suitable emulsifiers can be found in the patent of E.U.A. 5,085,856 to Dunphy et al .; Japanese Patent Publication Sho 61-83110; European patent application EP 522624 to Dunphy et al .; patent of E.U.A. 5,688,831 to El-Nokali et al. Examples of other suitable emulsifiers can be found in Cosmetic Bench Reference, pp. 1.22, 1.24-1.26 (1996), all incorporated herein by reference in their entirety.
Mixtures of the above surfactants and emulsifiers can also be used. A preferred optional component is ethylcellulose (Ethocel). Ethylcellulose is generally preferred for use at levels of about 5% and more preferably 1%. Another preferred optional component is silica. Silica is generally preferred for use at levels of about 1% and about 5%.
The hypoallergenic compositions can be made from the liquid crystal, wax, oils and colors of the present. These compositions should not contain fragrances, flavor oils, lanolin, sunscreens, particularly PABA or other potential sensitizers or sensitizers and irritants. The compositions of the present invention can also be made in long-lasting or non-transferable cosmetic compositions. Detailed discussions of such lipsticks are found in Japanese Patent Publication Hei No. 6-199630 and European Patent Application 748622, both incorporated herein by reference in their entirety. Additional optional materials that can be incorporated into the compositions of the present invention can be found in the PCT application WO 97/39733, for Oblong et al.
Methods of use The cosmetic compositions of the present invention are ideally suited for use in the treatment of skin and lips, especially in the form of a lipstick or a lip balm to apply a permanent or semi-permanent color to the lips, ideally with a finish bright or glossy. The cosmetic compositions can also be used in the treatment of the skin and / or lips with a skin care agent that protects against exposure to adverse weather, including wind and rain, dry and / or hot environments, pollutants environmental (for example, ozone, smoke and the like), or exposure to excessive doses of sunlight. The compositions are also useful for providing sun protection, moisturizing and / or conditioning for hair and skin, improved skin feel, regular skin texture, reducing fine lines and wrinkles, reducing oily shine in hair or skin, lightning skin and reduce odor in skin or hair. The cosmetic compositions, accordingly, can be applied to the skin and / or lips in the traditional manner using a suitable carrier or applicator to provide a decorative and / or protective film thereto.
Methods for determining solubility of vitamin B ^ compounds in emollients. The solubility of the vitamin B3 compound in the different non-polar emollients of the present invention can be determined as follows:
l. Preparation of samples for analysis: 1) the emollient is placed in a pre-weighed bottle and then saturated with a vitamin B3 compound; 2) the bottle is shaken and allowed to settle in a bath at 30 ° C for 1 hour. A small stirring bar is used to stir the contents of the jar. If precipitation does not occur in the bottle, then more niacinamide is added. This is repeated until precipitation occurs. The sample is left in the bath for an additional 48 hours to ensure saturation; 3) the saturated emollient is extracted in a syringe; 4) a 0.45 micron filter (Gelman Acrodisc) is fitted at the end of the syringe and the emollient is filtered in a separate pre-weighed jar for analysis; 5) The emollient is analyzed using CLAR to determine the amount of niacinamide in it.
II. Analysis: Approximately, 0.25 g of the sample (sample weight) is weighed into a 15 mL plastic screw cap centrifuge tube. The sample is mixed with approximately 3 mL of 50/50 v / v methanol / chloroform and homogenized by swirl mixture. Then, approximately 7 mL of water is added to extract the vitamin B3 compound from the methanol / chloroform phase. Each sample is mixed by stirring 50 times in a forward and backward movement to facilitate transfer of the niacinamide from methanol / chloroform to the aqueous phase. This mixture creates an emulsion at the interface of the two phases. The emulsion can be dissipated by letting the sample sit for several hours or by brief centrifugation (15 seconds) at high speed. Once the two phases have completely separated, a pipette is used to cally transfer the aqueous phase into a separate, previously weighed bottle.
The weight of the aqueous phase (weight of aqueous phase) is noted. An aliquot of the aqueous phase is transferred to an analysis container and analyzed for niacinamide by HPLC (Waters 2690 Separation Module coupled with a Waters 996 PDA detector, both supplied by Waters Corporations).
lll. Calculations: The percentage of vitamin B3 compound is determined by taking the concentration of vitamin B3 compound measured through CLAR and multiplying by the dilution factor. The dilution factor is the weight of the aqueous phase divided by the sample weight.
EXAMPLES
The cosmetic formulations illustrated in Examples I-X show specific embodiments of the cosmetic compositions of the present invention, but are not intended to limit the same. Those skilled in the art may attempt other modifications without departing from the spirit and scope of this invention. These exemplified embodiments of the cosmetic compositions of the present invention improve the skin penetration of the vitamin B3 compound and at the same time also improve the skin feel of the crystalline vitamin B3 compound.
All the exemplified compositions can be prepared by conventional formulation and mixing techniques. Such formulation and mixing techniques are described in detail in Harry's Cosmeticoloqy, p. 119-141 and 314-354 (J.B. Wilkinson and R.J. Moore 7th edition 1982), and Cosmetics: Science and Technoloqy, pp. 1-104 and 307-422 (M.S. Balsam and E. Sagarin 2nd edition 1972), both incorporated herein by rence in their entirety. Component amounts are mentioned as percentages by weight and minor materials such as diluents, filler, etc. are excluded. There, the mentioned formulations comprise the mentioned components and any minor material associated with such components.
EXAMPLE Composition of lipstick
Quantity Ingredient (percent by weight)
Ozokerite wax 5.00 Candelilla wax 3.00 Caranauba wax 2.00 Cetyl alcohol 2.00 Cetyl lactate 2.00 Ascorbyl palmitate 0.50 Propylparaben 0.10 Vitamin E acetate 0.05 Isopropyl isostearate 13.97 Octyl hydroxystearate 5.20 Paraffin wax 2.50 2N-nicotinic acid oxide (23 %) + castor oil (77%) 21.74 Acetylated lanolin 6.33 Mica SVA1 10.00 Pigment suspension (30% pigment / 70% castor oil 25.61)
1 Mica treated with lauroyl lysine, Mearlmica SVA, supplied by Mearl 2 In a suitable, pure container chemically synthesized niacinamide is dissolved using an appropriate solvent (for example, water, alcohol such as ethanol, polyhydric alcohols and the like). The N-oxide of nicotinic acid is subsequently recrystallized by a single method of the solvent. The recrystallized nicotinic acid N-oxide is combined with the castor oil and milled to the appropriate particle size.
Separately, the mixture of the cylindrical crystalline nicotinic acid N-oxide castor oil mixture with the remaining ingredients of the above formulation is added to a vessel equipped with a heat source and the ingredients are heated to a temperature of about 90 ° C to form a fusion. The fusion is mixed until it becomes homogeneous. The mixture is evacuated under vacuum and poured into the appropriate mold. The mixture is cooled to room temperature and incorporated into the proper packaging.
The lipstick is applied to the lips to provide color, moisture and improved feeling in the lips.
EXAMPLE II Pencil Composition I Labial Quantity Ingredient (percent by weight)
Ozokerite wax 5.00
Candelilla wax 3.00
Caranauba wax 2.00
Cetyl Alcohol 2.00
Cetyl lactate 2.00
Ascorbyl Palmitate 0.50
Propylparaben 0.10
Vitamin E acetate 0.05
Isopropyl isostearate 15.00
Octyl hydroxystearate 10.00
Paraffin wax 2.50
Niacinamide1 2.50
Castor oil 13.41
Acetylated lanolin 6.33
Mica SVA 10.00
Pigment suspension (30% pigment / 70% castor oil 25.61) In a suitable, pure container, chemically synthesized niacinamide is dissolved using an appropriate solvent. Subsequently, the niacinamide is crystallized again by means of the binary solvent method.
The recrystallized niacinamide is then milled to the appropriate particle size. Separately, the ground cylindrical crystalline niacinamide, together with the remaining ingredients of the above formulation are added to a vessel equipped with a heat source and the ingredients are heated to a temperature of about 90 ° C to form a melt. The fusion is mixed until it becomes homogeneous. The mixture is evacuated under vacuum and poured into the appropriate mold. The mixture is cooled to room temperature and incorporated into the proper packaging. The lipstick is applied to the lips to provide color, moisture and improved feeling in the lips.
EXAMPLE Composition of lipstick
Ingredient Quantity (weight percent) Glycerin 0.300 Lecithin 2.00 Niacinamide 5.00 Octayl Palmitate 10.24 Isopropyl Palmitate 4.80 Bentona 38 1.00 Propylene Carbonate 0.33 Cetyl Recinolate 1.00 Diisopropyl Ditearate 29.88 Lanolin Oil 11.60 Ozokerite 6.75 Candelilla 5.25 Be Square 175 2.00 Diisostearate of PG-3 2.00 Acetate of vitamin "E" 0.05 Propiiparaben 0.15 Methylparaben 0.15 Benzoic acid 0.10 Mica cf 7.00 Pigments 9.00 Dyes 0.40
Mica untreated, Mearlmica MMCF, supplied by Mearl.
In a suitable, pure container, chemically synthesized niacinamide is dissolved using an appropriate solvent. Subsequently, the niacinamide is recrystallized by means of a single solvent method and milled to the appropriate particle size and cylindrical shape. Next, the glycerin, lecithin and milled niacinamide are mixed in a suitable vessel until a liquid crystal phase is formed.
Separately, the remaining ingredients of the above formulation are added to a vessel equipped with a heat source and heated to a temperature of about 90 ° C to form a melt. The fusion is mixed until it becomes homogeneous. The above liquid crystalline phase mixture is added to the melt and mixed until it becomes homogeneous. The mixture is evacuated under vacuum and poured into the appropriate mold. The mixture is cooled to room temperature and incorporated into the proper packaging.
The lipstick is applied to the lips to provide color, moisture and improved feeling in the lips.
EXAMPLE IV Deodorant gel bar
Ingredient Quantity (weight percent)
Niacinamide 4 Acid-di-n-butylamide N-lauroyl-L-glutamic acid1 4 12-Hydroxystearic acid 2 Light mineral oil2 23 Diisopropyl sebacate3 39 Aluminum-zirconium 25 Talc 3
1GP-1 supplied by Ajinomoto, Inc. 2 Benol White Mineral Oil supplied by Witco Chemical
Corp. 3Schercemol DIS supplied by Scher Cherfficals Inc.
In a suitable, pure container, chemically synthesized niacinamide is dissolved using an appropriate solvent. Subsequently, niacinamide is recrystallized by a single solvent method. Next, the recrystallized niacinamide is milled to the appropriate particle size and cylindrical shape. Separately, the gelling agent, the recrystallized niacinamide and the liquid base material are combined in a vessel equipped with a heat source. The mixture is heated to a temperature between about 80 ° C and about 130 ° C with stirring, until the mixture forms a homogeneous, molten solution. Preferably, the homogeneous, molten solution is allowed to cool to a mixing temperature; typically between about 65 ° C and 110 ° C. Then, the active deodorant and other ingredients are added to the melt, such as fragrances and colors, in the homogeneous solution, melted in the previous vessel with agitation. The mixture is allowed to cool until it begins to thicken and is poured into containers that are allowed to cool to room temperature. (Although not preferred, the deodorant active may alternatively be added together with the gelling agent and the liquid base material in the first step). A deodorant composition, formed according to the above, is applied in the area of the armpit of a human subject, and reduces perspiration in the area that is applied, improves the odor in this area, and improves the feeling of the skin.
EXAMPLE V Solid Deodorant Stick
Inqredient Quantity (weight percent)
Niacinamide 8.0 Stearyl alcohol 10.0 Hydrogenated castor oil mp 86 ° C 4.00 Aluminum chlorhydroxide 40.0 Isopar "V" 1 37.0 Fragrance 1.0 100.0
1sopar "V" Weight. Mol. Prom. 197 P.E. scale, 255-301 degrees Celsius. In a suitable, pure container, chemically synthesized niacinamide is dissolved using an appropriate solvent. The niacinamide is subsequently recrystallized by a binary solvent method. Next, the recrystallized niacinamide is milled to the appropriate particle size and cylindrical shape. In a separate container containing a heat source, the isoparaffin liquids, the water-insoluble liquid emollients, the surface active agent and the water-insoluble waxes are heated to a temperature sufficient to form a solution of these materials. Then, aluminum chlorhydroxide is added with moderate agitation, followed by the recrystallized niacinamide and the remaining ingredients. The solution is mixed until a homogeneous suspension is formed. The suspension is cooled to a temperature above the solidification point and then poured into suitable containers. A deodorant composition, formed according to the above, is applied in the area of the armpit of a human subject and reduces perspiration in the area that is applied, improves the odor in this area, and improves the feeling of the skin.
EXAMPLE VI Solid deodorant stick
Inqredient Quantity (weight percent)
Nicotinic acid 2.5 Stearic acid 10.0 Hydrogenated castor oil mp 86 ° C 4.0 Zirconium chlorhydroxide 25.0 Talc 10.0 Isopar "M" 1 42.5 Diisopropyl adipate 5.0 Fragrance 1.0 100.0
1lsopar "V" Weight. Mol. Prom. 191 P.E. scale, 207-260 degrees Celsius. In a suitable, pure container, chemically synthesized niacinamide is dissolved using an appropriate solvent. The nicotinic acid is subsequently recrystallized by a single solvent method. Next, the recrystallized nicotinic acid is milled to the appropriate particle size and cylindrical shape.
In a separate container containing a heat source, the isoparaffin liquids, the water-insoluble liquid emollients, the surface active agent and the water-insoluble waxes are heated to a temperature sufficient to form a solution of these materials. Then, aluminum chlorhydroxide is added with moderate agitation, followed by recrystallized nicotinic acid and the remaining ingredients. The solution is mixed until a homogeneous suspension is formed. The suspension is cooled to a temperature above the solidification point and then poured into suitable containers. A deodorant composition, formed according to the above, is applied in the area of the armpit of a human subject and reduces perspiration in the area that is applied, improves the odor in this area, and improves the feeling of the skin.
EXAMPLE VII Solid deodorant cream
Ingredient Quantity (weight percent)
Niacinamide 3.0 Cyclomethicone (D5) 40.5 Dimethicone (350 cs) 4.0 Cab-O-Sil HS-51 4.0 Microtensile FN5102 6.0 Natrosol3 2.0 Iso-eicosano4 13.0 Reach AZ5 26.7 Fragrance 0.8 1 Colloidal silica thickener material, sold by Cabot Corporation. 2 Low density polyethylene powder, sold by U.S. I. Chemicals. 3Hydroxyethylcellulose, sold by Hercules, Inc. 42,2,4,4,6,6,8,8-dimethyl-10-methylundecane, obtained from Permethyl Corporation, Frazier, PA. 5 Complex of zirconium-aluminum-glycine hydroxychloride, active particulate deodorant material, sold by Reheis Chemical Company. In a suitable, pure container, chemically synthesized niacinamide is dissolved using an appropriate solvent. The niacinamide is subsequently recrystallized by the binary solvent method. Next, the recrystallized niacinamide is milled to the appropriate particle size and cylindrical shape. The cyclomethicone, dimethicone, iso-eicosane and perfume are added to a stainless steel mixing vessel. Then Cab-O-Sil is added, followed by Microteno and Natrosol and finally, the active deodorant and recrystallized niacinamide. The composition is completely stirred after the addition of each particulate material. Then the composition is milled, using a Black &; Decker (Model 4420, type 4) with a Cowles dispersion blade of 6.35 cm in diameter at approximately 6,000 rpm, for approximately 5 minutes. The penetration force value of the milled composition is about 300 grams at 25 ° C and relative humidity of 50%. A deodorant cream formulation, formed according to the above, is applied to the underarm area of a human subject and reduces perspiration in the area being applied, improves the odor in this area, and improves the skin feel.
EXAMPLE Vlll Waterproof mascara
Ingredient Quantity (weight percent
Petroleum distillate ((IBP 345) 50,120 Glyceryl resin liquid rosin 10,000 Bentona 38 CG or Type 5,890 Color (black 34-3068 or type) 5,000 rented PVP (type 220) 5,000 Trihydroxystearin (type R) 5,000 Magnesium carbonate 309 5,000 N-oxide of nicotinic acid 5,000 Caolin 2747 2,000 Carnauba wax, NF 2,000 Propylene carbonate 1,940 Polyethylene AC-617a 1,000 Phenoxyethanol 0.250 Color (yellow 34-3170 or type) 1,600 Propylparaben, NF 0.100 Tenor BHA 0.100 Total 100,000
In a suitable, pure container, chemically recrystallized N-oxide of nicotinic acid is dissolved using an appropriate solvent. The N-oxide of nicotinic acid is subsequently recrystallized by a single solvent method. Next, the recrystallized nicotinic acid N-oxide is milled to the appropriate cylindrical particle size and shape. Next, the ground recrystallized nicotinic acid N-oxide and the above ingredients with the exception of the dyes and gelling / fillers, are added in a stainless steel mixing vessel equipped with a heat source. The ingredients are heated to a temperature of about 90 ° C, and mixed using a propeller blade. Once the temperature reaches approximately 90 ° C, the ingredients are mixed using a disperser blade at approximately 3500 rpm. The pigments are then slowly added during mixing with the disperser. In a similar manner, gelling agents / fillers are added with mixture. The mixture continues with the disperser until the mixture is homogeneous. The mixture is then allowed to cool while mixing with the disperser at 3500 rpm. At about 40 ° C, the mixture is discontinued and the mixture is transferred into a suitable storage container. The mascara composition is applied to the eyelashes and / or eyebrows to provide softness, moisture and improved feeling.
EXAMPLE IX Mascara I
Inquired Quantity (weight percent
Petroleum distillate ((IBP 345) 52,120 Glyceryl esters of rosin and Inequid resin 10,000 Bentona 38 CG or Type 5,890 Magnesium carbonate 309 5,000 Alloyed PVP (type 220) 5,000 Trihydroxystearin (type R) 5,000 Talc 2755 4,790 Niacinamide 3,000 Caolina 2747 2,000 Carnauba wax, NF 2,000 Propylene carbonate 1,940 Polyethylene AC-617a 1,000 Phenoxyethanol 0.250 Propylparaben, NF 0.100 Tenox BHA 0.100 Color (blue 3403516 or type) 1,810 Total 100,000
The composition is prepared and used as in example Vlll.
EXAMPLE X Mascara
Ingredient Quantity (weight percent
Petroleum distillate ((IBP 345) 51.220 Glyceryl ester of liquid resin rosin 10,000 Bentona 38 CG or Type 5.890 Magnesium carbonate 309 5,000 Trihydroxystearin (type R) 5,000 Carnauba wax, NF 2,000 Niacinamide 10,000 Caolina 2747 2,000 Propylene carbonate 1,940 Polyethylene AC-617a 1,000 Phenoxyethanol 0.250 Color 5.500 Tenox BHA 0.100 Propylparaben, NF 0.100 Total 100,000
The composition is prepared and used as in Example VIII.
EXAMPLE XI Lipstick
Ingredient% by weight Polybutene 4.536 Lanolin oil 18.342 Octoxiglyceryl behenate 18.342 Stearyl heptanoate 8.856 Jojoba oil 8.856 Castor oil 21.78 Butylated hydroxytoluene 0.054 Butylated hydroxyanisole 0.054 Microcrystalline wax 6.84 Polyethylene 500 6.84 Niacinamide 4.5 (amphiphilic lipid phase) Lecithin 0.475 Cholesterol 0.475 Phosphate of dicetio 0.05
In a suitable, pure container, chemically synthesized niacinamide is dissolved using an appropriate solvent. The niacinamide is subsequently recrystallized by a single solvent method. Next, the recrystallized niacinamide is combined with the castor oil and milled to the appropriate particle size and cylindrical shape. Separately the mixture of ground cylindrical crystalline niacinamide / castor oil, polybutene, lanolin oil, octoxiglyceryl behenate, stearyl heptanoate, jojoba oil, butylated hydroxytoluene, butylated hydroxyanisole, microcrystalline wax, polyethylene 500 is added to a vessel equipped with a heat source and heated to a temperature of about 100 -110 ° C to form a fusion. The fusion is mixed until it becomes homogeneous. The lecithin, cholesterol and dicetyl phosphate are mixed separately under nitrogen and at a temperature of about 110 ° C. The mixture containing lecithin is then added to the mixture containing niacinamide and mixed until it becomes uniform. The mixture is evacuated under vacuum and poured into the appropriate mold. The mixture is cooled to room temperature and incorporated into the proper packaging. The lipstick is applied to the lips to provide color, moisture and improved feeling in the lips.
EXAMPLE XII Lip Balm
Ingredient% by weight Cotone of SEFA 84,000 Niacinamide 5,000 Candelilla wax 3,000 Ozokerite wax 1,000 Microcrystalline wax 1,500 Beeswax 5,300 BHT 0.050 Ethylene brazilate 0.050 Propylparaben 0.100 100,000
In a suitable, pure container, chemically synthesized niacinamide is dissolved using an appropriate solvent. The niacinamide is subsequently recrystallized by a single solvent method. Next, the recrystallized niacinamide is mixed with SEFA cotonate and milled to the appropriate cylindrical particle size and shape. The mixture of SEA niacinamide cotonate together with the remaining ingredients is added to a vessel equipped with a heat source and heated to a temperature of about 80-90 ° C to form a melt. The fusion is mixed until it becomes homogeneous. The air is removed from the mixture by vacuum and poured into the appropriate mold. The mixture is cooled to room temperature and incorporated into the proper packaging. The lip balm is applied to the lips to provide moisture and improved feeling in the lips.
EXAMPLE XIII Long-lasting cosmetics
A long-lasting cosmetic according to the present invention is prepared in the following manner: A. A mixture (part A) is prepared by combining the following ingredients in a suitable container:
Inqredient% by weight Resin MQ1 43.7 PM99A2 56.3
1Trimet¡ls¡lox¡slicato available from GE.
2lsodedecano available from Presperse. The mixture is incorporated using conventional mixing techniques until the MQ resin is dissolved.
Processing B. A mixture (part B) is prepared by combining the following ingredients in a suitable container:
Ingredient% by weight Silicone rubber SSE301 50.0 PM99A 50.0 available from GE1
The mixture is incorporated using conventional mixing techniques until the silicone rubber SE30 is dissolved. C- A lipstick containing part A and part B is prepared by combining the following ingredients:
Ingredients% by weight 1 Tocopherol nicotinate 1.00 Part A 47.00 Part B 24.91 Pigment (s) 10.00 Propylparaben 0.20 PM99A 1.89 Bentona ISD2 15.00
1 Cylindrical crystalline ticoferinate nicotinate with an average particle size of about 0.01% to about 50%, by weight, having a particle size distribution such that at least about 70% of the crystalline particles have a height ratio Width greater than 1. 210% Benton, 3% Propylene Glycol, 87% Isooxid available from Rheox In a suitable container, the mixture of Part A together with the pigments, propylparaben, cylindrical crystalline tocopheryl nicotinate and PM99A are combined and mixed using a Ross homogenizer at approximately 4,000 rpms for approximately 10 minutes or until the mixture is uniform (taking care not to ignite the PM99A). Bentona ISD is added to the blend combination at approximately 4,000 rpms until the mixture is uniform. The mixture of part B is added to the mixture and is initially incorporated at high shear force, preferably 1600 rpms, to facilitate dispersion using an IKA mixer. Once sufficient dispersion is achieved, the mixer speed is reduced, preferably to about 1,000 rpms, and the mixture is allowed to incorporate until it is uniform. The mixture is then poured into a suitable container and sealed for storage, preferably at room temperature. The long-lasting cosmetic composition is applied to the skin to provide color, moisture and improved skin feeling.
Claims (24)
1. - A lipstick composition containing crystalline compounds of vitamin B3, and which provides improved sensation in the skin, said composition comprising: a) from about 0.01% to about 50% by weight, of a crystalline vitamin B3 compound having an average particle size of about 0.01 μm to about 200 μm; b) from about 1% to about 90% by weight of an emollient component; and c) from about 1% to about 90% by weight, of a solidifying agent.
2. The lipstick composition according to claim 1, further characterized in that the average particle size of the vitamin B3 compound is from about 0.1 μm to about 100 μm.
3. The lipstick composition according to claim 1, further characterized in that at least 60% of the vitamin B3 compound has a particle size of less than 30 μm.
4. The lipstick composition according to claim 1, further characterized in that said vitamin B3 compound is selected from the group consisting of niacinamide, niacinamide derivatives, non-vasodilating esters of nicotinic acid and combinations thereof.
5. The composition of lipstick according to claim 4, further characterized in that said vitamin B3 compound is selected from the group consisting of niacinamide, tocopherol nicotinate and combinations thereof.
6. The lipstick composition according to claim 5, further characterized in that said vitamin B3 compound is niacinamide.
The lipstick composition according to claim 1, further characterized in that said vitamin B3 compound is substantially free of salts of the vitamin B3 compound.
8. The lipstick composition according to claim 1, further characterized in that said vitamin B3 compound is not substantially combined.
9. The lipstick composition according to claim 1, further characterized in that said composition is substantially free of polar solvents.
10. The lipstick composition according to claim 1, further characterized in that said emollient component comprises from about 10% to about 80% of the cosmetic composition.
11. The lipstick composition according to claim 10, further characterized in that said oil comprises from about 5% to about 90% of the emollient component.
12. The composition of lipstick according to claim 10, further characterized in that said emollient is a non-polar emollient.
13. The lipstick composition according to claim 10, further characterized in that said oil is selected so that at least about 75% of the types of oils used have solubility parameters that do not differ by more than about 0.1. to about 1.
14. The lipstick composition according to claim 13, further characterized in that said oil is selected so that at least about 99% of the types of oils used have solubility parameters that do not differ in more than about 0.1 to about 1.5.
15. The lipstick composition according to claim 1, further comprising from about 0.1% to about 35% of a color.
16. The composition of lipstick according to claim 1, further characterized in that the vitamin B3 compound is dispersed in the emollient.
17. - A method for improving the perceived skin feel of crystalline vitamin B3 compounds by applying a safe and effective amount of the lipstick composition of claim 1 to the skin.
18. The lipstick composition in accordance with claim 1, further characterized in that the composition comprises less than about 10% by weight of water of the composition formed.
19. A topical cosmetic composition that provides improved skin feel of crystalline vitamin B3 compounds, said composition comprising: a) from about 0.1% to about 50% by weight of a crystalline vitamin B3 compound having a particle size average of about 0.1 μm to about 200 μm; and b) from about 1% to about 90%, by weight of an emollient component.
20. The composition according to claim 19, further characterized in that the vitamin B3 compound is niacinamide.
21. The composition according to claim 19, further characterized in that the vitamin B3 compound is dispersed in the emollient.
22. The composition according to claim 19, further characterized in that the average particle size of the vitamin B3 compound is from about 0.01 μm to about 100 μm.
23. - The composition according to claim 19, further characterized in that the composition is substantially free of polar solvents.
24. The composition according to claim 19, further characterized in that the vitamin B3 compound is dispersed in the emollient.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/249,653 | 1999-02-12 | ||
US09473336 | 1999-12-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA01008185A true MXPA01008185A (en) | 2002-03-26 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1152733B1 (en) | Cosmetic compositions containing vitamin b3 | |
EP1152732B1 (en) | Cosmetic compositions containing vitamin b3 | |
AU769065B2 (en) | Cosmetic compositions containing vitamin B3 compounds | |
EP1150645B1 (en) | Cosmetic compositions containing vitamin b3 | |
MXPA01008185A (en) | Cosmetic compositions containing vitamin b3 | |
MXPA01008186A (en) | Cosmetic compositions containing vitamin b3 |